Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash	$ 25,499	$ 19,639
Accounts receivable	219	61
Inventory	687	278
Prepaid expenses, deposits, and other current assets	3,802	4,520
Total current assets	30,207	24,498
Fixed assets, net	1,331	1,783
Operating lease right-of-use assets	5,771	4,267
Intangible assets, net	947	1,424
Other assets	1,157	1,147
Total assets	39,413	33,119
Current liabilities:
Accounts payable	1,232	1,786
Accrued expenses and other current liabilities	6,789	6,626
Operating lease liabilities, current portion	1,369	1,565
Senior Secured Convertible Notes - at fair value	44,000	44,200
Total current liabilities	53,390	54,177
Operating lease liabilities, less current portion	4,665	2,960
Total liabilities	58,055	57,137
Commitments and contingencies (Note 8)
Stockholders’ Equity:
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,357,976 at June 30, 2024 and 1,305,213 shares at December 31, 2023	3,151	2,993
Common stock, $0.001 par value. Authorized, 50,000,000 shares; 9,554,381 and 8,578,505 shares outstanding as of June 30, 2024 and December 31, 2023, respectively	10	9
Additional paid-in capital	243,524	237,600
Accumulated deficit	(320,630)	(294,433)
Total PAVmed Inc. Stockholders’ Equity (Deficit)	(73,945)	(53,831)
Noncontrolling interests	55,303	29,813
Total Stockholders’ Equity (Deficit)	(18,642)	(24,018)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 39,413	$ 33,119